Lipocine
LPCN
LPCN
39 hedge funds and large institutions have $13M invested in Lipocine in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
53% less call options, than puts
Call options by funds: $566K | Put options by funds: $1.21M
Holders
39
Holding in Top 10
–
Calls
$566K
Puts
$1.21M
Top Buyers
| 1 | +$585K | |
| 2 | +$310K | |
| 3 | +$228K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$43K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$41K |
Top Sellers
| 1 | -$2.41M | |
| 2 | -$970K | |
| 3 | -$908K | |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$397K |
| 5 |
Millennium Management
New York
|
-$204K |